FOLLISTATIN
Despite extensive animal research showing dramatic muscle gains, human data remains surprisingly limited with only 4 human studies out of 30 total. The evidence gap between laboratory promise and clinical reality is substantial.
Primarily investigated by researchers studying muscular dystrophy, cachexia, and age-related muscle loss, with growing interest from sports medicine scientists examining performance enhancement applications.
Since Feb 2026
30 total, 4 human
What is FOLLISTATIN?
Among the most intensively studied compounds in muscle development research, this naturally occurring glycoprotein has captured scientific attention for its ability to override the body's built-in muscle growth limits. Researchers investigating muscle wasting diseases, age-related sarcopenia, and athletic performance enhancement frequently examine follistatin's potential to dramatically increase muscle mass beyond normal physiological boundaries.
The protein works by acting as a molecular sponge, capturing and neutralizing myostatin—the body's natural muscle growth brake system—along with activin, another growth-limiting factor. Think of it as removing the governor from an engine: by binding these inhibitory signals, follistatin theoretically allows muscles to grow far beyond their normal genetic programming, which is why it's generated such intense research interest.
What the Research Shows
While 30 studies sounds impressive, only 4 involved human subjects, creating a significant translation gap between promising animal results and clinical applications.
Out of 30 total studies (25 human studies, 5 RCTs), resistance training combined with follistatin-related interventions demonstrated improvements in muscle strength, grip strength, and functional fitness, with additional evidence from animal models showing that FAST-PLV gene therapy with follistatin DNA increased muscle mass and grip strength. Creatine supplementation paired with resistance training enhanced strength and muscle mass while improving anabolic hormone ratios, though comparative analyses suggest conventional resistance training outperforms blood flow restriction and vibration-based approaches for muscle mass gains.
Notable Studies
Bagheri N, Bagheri R, Mesinovic J et al. · Med Sci Sports Exerc (2025)
RCT · n=6012 · weeks
Eghbali E, Arazi H, Suzuki K · Physiol Res (2024)
RCT · n=408 · weeks
Zhuang M, Gu Y, Wang Z et al. · Sci Rep (2025)
RCT · n=2712 · weeks
Seo MW, Jung SW, Kim SW et al. · Int J Environ Res Public Health (2021)
RCT · n=2216 · weeks
Zhang M, Song Y, Zhu J et al. · Sci Rep (2024)
RCT · n=2112 · weeks
Reported Benefits
Regulatory Status
Last verified: Feb 2026
Related Peptides
This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.